Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Efficacy of a non-invasive middle ear aeration device in children with recurrent otitis media: A randomized
Tristan Tham1, Lauren Rahman1, Peter Costantino1
1Department of Otolaryngology - Head and Neck Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA.
Insights
This study evaluates the EarPopper device (EP) for reducing acute otitis media (AOM) in children. Results will show if this non-invasive device can decrease AOM episodes in kids with recurrent ear infections.
Area of Science:
- Pediatric Otolaryngology
- Clinical Trials
- Medical Device Efficacy
Background:
- Acute otitis media (AOM) significantly impacts children's health.
- Current preventive measures for AOM in children are limited beyond vaccinations.
- Recurrent AOM poses a substantial burden on pediatric patients and healthcare systems.
Purpose of the Study:
- To assess the efficacy of the EarPopper device (EP) in reducing AOM incidence in children with recurrent infections.
- To investigate the impact of the EP on time to AOM, antibiotic use, and quality of life.
- To provide evidence for a non-invasive intervention for managing pediatric recurrent AOM.
Main Methods:
- Randomized controlled trial comparing an intervention group using the EP with an observational control group.
- Inclusion criteria: children aged 4-11 with a history of recurrent AOM.
- Primary endpoint: incidence of AOM. Secondary endpoints include time to AOM, antibiotic use, and quality of life (OMO-22 Form).
Main Results:
- Study is a randomized controlled trial evaluating the EarPopper device for recurrent AOM in children.
- The primary outcome is the incidence of AOM in the intervention and control groups.
- Secondary outcomes include time to AOM, antibiotic use, and quality of life measures.
Conclusions:
- The EarPopper device is being evaluated as a novel, non-invasive method to manage recurrent AOM in children.
- Findings will inform clinical practice regarding the use of middle ear aeration devices.
- This trial aims to establish the EP's effectiveness in reducing AOM episodes and improving pediatric health outcomes.
Abstract:
Acute otitis media (AOM) represents a significant disease burden in the pediatric population. Besides vaccinations, there are no robust measures of reducing incidence of AOM in this age-group. This is a randomized controlled clinical trial evaluating the efficacy of a non-invasive middle ear aeration device, the EarPopper device (EP). We aim to investigate the reduction of episodes AOM in children with recurrent otitis media. The control arm will be observational. The intervention arm will have the EP used. The primary endpoint is incidence of AOM. The secondary endpoints are hazard ratio of time to AOM, proportion without AOM and antibiotics use, quality of life (OMO-22 Form), and adherence to treatment. Sample size is a minimum of 150 patients. The inclusion criteria is ages 4-11, with history of recurrent Acute Otitis Media (AOM).
Related Concept Videos
Self-Efficacy
Clinical Trials: Overview
Trial and Error and Algorithm
Clinical Trials
There are four phases in a clinical trial. A phase one...
Anatomy of the Ear
Random Error

